Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions

Otology and Neurotology

Volumn 30, Issue 5, 2009, Pages 676-680

  De Azevedo, Andréia Aparecida ^a,d   Langguth, Berthold ^b   De Oliveira, Patricia Mello ^a   Rodrigues Figueiredo, Ricardo ^a,c  

^a OTOSUL   (Brazil)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Valença Medical School   (Brazil)

^d NONE   (Brazil)

Author keywords

Dopamine agonist; Electrocochleography; Otoacoustic emissions; Piribedil; Tinnitus

Indexed keywords

PIRIBEDIL; PLACEBO;

ADULT; AGED; ARTICLE; AUDIOMETRY; AUDITORY LATERALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ELECTROCOCHLEOGRAPHY; EPIGASTRIC PAIN; FEMALE; GASTRIC FULLNESS; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TREATMENT RESPONSE; VISUAL ANALOG SCALE; VISUAL DISORDER;

AGED; AUDIOMETRY, EVOKED RESPONSE; CROSS-OVER STUDIES; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PIRIBEDIL; TINNITUS;

EID: 68849119478     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181ab8fd5     Document Type: Article

References (24)

1. Moller AR. Tinnitus: presence and future. Prog Brain Res 2007;166:3-16.
2. Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999;109:1202-1211 (Pubitemid 29379426)
3. Moller AR. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. Am J Otol 1997;18:268-269
4. Kleinjung T, Steffens T, Londero A, et al. Transcranial magnetic stimulation (TMS) for treatment of chronic tinnitus: clinical effects. Prog Brain Res 2007;166:359-367 (Pubitemid 47588081)
5. Puel JL, Ruel J, Guitton M, et al. The inner hair cell afferent/efferent synapses revisited: a basis for new therapeutic strategies. Adv Otorhinolaryngol 2002;59:124-130 (Pubitemid 34253012)
6. Ruel J, Wang J, Dememes D, et al. Dopamine transporter is essential for the maintenance of spontaneous activity of auditory nerve neurons and their responsiveness to sound stimulation. J Neurochem 2006;97:190-200.
7. Ruel J, Nouvian R, Gervais d'Aldin C, et al. Dopamine inhibition of auditory nerve activity in the adult mammalian cochlea. Eur J Neurosci 2001;14:977-986
8. Gaborjan A, Lendvai B, Vizi ES. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea. Neuroscience 1999;90: 131-138 (Pubitemid 29096459)
9. d'Aldin C, Puel JL, Leducq R, et al. Effects of a dopaminergic agonist in the guinea pig cochlea. Hear Res 1995;90:202-211
10. Pujol R, Puel JL, Gervais d'Aldin C, et al. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol 1993; 113:330-334
11. Hastak SM. Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting. J Indian Med Assoc 2003;101:500-501
12. Morand N, Khalfa S, Ravazzani P, et al. Frequency and temporal analysis of contralateral acoustic stimulation on evoked otoacoustic emissions in humans. Hear Res 2000;145:52-58 (Pubitemid 30365266)
13. Riga M, Papadas T, Werner JA, et al. A clinical study of the efferent auditory system in patients with normal hearing who have acute tinnitus. Otol Neurotol 2007;28:185-190 (Pubitemid 46175118)
14. Langguth B, Goodey R, Azevedo A, et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res 2007;166:525-536
15. Schmidt LP, Teixeira VN, Dall'Igna C, et al. Brazilian Portuguese language version of the "Tinnitus Handicap Inventory": validity and reproducibility. Braz J Otorhinolaryngol 2006;72:808-810
16. Ma J, Ye N, Lange N, et al. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus. Neuroscience 2003;121:991-998 (Pubitemid 37324598)
17. Csomor PA, Stadler RR, Feldon J, et al. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 2008;33:497-512.
18. Langguth B, Eichhammer P, Spranz C, et al. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl) 2008;196:623-629
19. Vrim-Ucok M, Keskin-Ergen HY, Ucok A. P50 gating at acute and post-acute phases of first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1952-1956
20. Lockwood AH, Salvi RJ, Coad ML, et al. The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity. Neurology 1998;50:114-120 (Pubitemid 28106029)
21. Muhlau M, Rauschecker JP, Oestreicher E, et al. Structural brain changes in tinnitus. Cereb Cortex 2006;16:1283-1288
22. Eichhammer P, Hajak G, Kleinjung T, et al. Functional imaging of chronic tinnitus: the use of positron emission tomography. Prog Brain Res 2007;166:83-88 (Pubitemid 47588061)
23. Pettigrew AM, Liberman MC, Kiang NY. Click-evoked gross potentials and single-unit thresholds in acoustically traumatized cats. Ann Otol Rhinol Laryngol Suppl 1984;112:83-96.
24. Majumdar B, Mason SM, Gibbin KP. An electrocochleographic study of the effects of lignocaine on patients with tinnitus. Clin Otolaryngol Allied Sci 1983;8:175-180